CAT0045_Arnaldo+De+Lisio+Photo_500+x+535_homepage.jpg

Arnaldo De Lisio Joins Catalyst Advisors as Partner, Expanding the Firm’s European Presence

We are pleased to announce that Arnaldo De Lisio has joined Catalyst Advisors as a Partner in our London office. Arnaldo, who is fluent in English, Italian and German, brings deep experience working with clients to build boards and leadership teams in innovative areas of medicine, including immuno-oncology, oncology and rare diseases. Arnaldo joining the firm is the first step of a long-term plan to expand our global footprint. 

Building an Early-Stage Management Team: 
A Platform for Value Creation

For early-stage biopharma companies, having the right management team is just as important—if not more so—than investors and capital. Catalyst Advisors' Stephen J. Williams, Ph.D., walks through the common pitfalls and best practices around this critical task.

Going to Market: CEO Recruitment at a Critical Inflection Point

When a biopharma firm makes the jump from clinical to commercial, the board often brings in a new CEO with experience in navigating the new demands this evolution brings. Recruitment industry news source Hunt Scanlon takes a look at how Catalyst Advisors worked with three such biopharma companies to land the right chief executive.

Connect with us on LinkedIn
for our latest perspectives on biopharma leadership trends
and industry developments